Bunnage Mark E.
SEC insider (Form 3/4/5 filer). CIK 0002100735. EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX). 10 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in BOSTON, MA.
Companies Bunnage Mark E. has filed insider reports for
- VERTEX PHARMACEUTICALS INC / MA (VRTX): Officer, EVP, Chief Scientific Officer
Bunnage Mark E.
CIK: 0002100735
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERTEX PHARMACEUTICALS INC / MA
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- May 15, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect33 shares at avg. $453.45$15K - Feb 25, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect620 shares at avg. $486.35$302K - Feb 24, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect582 shares at avg. $485.11$282K - Feb 18, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect1.2K shares at avg. $473.68$560K - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirect2.6K shares- - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect1.1K shares at avg. $483.75$537K - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect2.4K shares at avg. $489.46$1.2M - Feb 13, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect2.3K shares at avg. $487.76$1.1M - Feb 11, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect2K shares at avg. $460.43$931K - Feb 10, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect1.1K shares at avg. $468.41$528K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 33 | $453.45 | $14,964 | Direct |
| Feb 25, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 620 | $486.35 | $301,537 | Direct |
| Feb 24, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 582 | $485.11 | $282,334 | Direct |
| Feb 18, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 1,182 | $473.68 | $559,890 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award | 2,584 | - | $0 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 1,110 | $483.75 | $536,963 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 2,437 | $489.46 | $1,192,814 | Direct |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 2,283 | $487.76 | $1,113,556 | Direct |
| Feb 11, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 2,021 | $460.43 | $930,529 | Direct |
| Feb 10, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 1,127 | $468.41 | $527,898 | Direct |
1-10 of 10 transactions